1. Nanomaterials: classification, composition, and recent advances in synthesis 2. Applications of nanoengineered therapeutics and vaccines: special emphasis on COVID-19 3. Nanomaterials and immune system 4. Methods for evaluation of the immunomodulatory effects of nanoparticles 5. Recommendations and use of multiplex biomarker assays 6. Precautions during evaluation of immunotoxicity of particulate materials 7. Data analysis and interpretation
Prof Mahmoud Elsabahy is a professor of pharmaceutical technology and nanomedicine with more than 15 years of experience in the development of cutting-edge technologies for gene therapy and biomedical delivery applications. He is currently a visiting scholar at the Texas A&M University, Texas, United States; vice dean of the School of Biotechnology and head of Science Academy, Badr University in Cairo (BUC), Cairo, Egypt; and a professor at the Faculty of Pharmacy, Assiut University, Assiut, Egypt. From 2011 to 2020, he was the assistant director of the Laboratory for Synthetic-Biologic Interactions at Texas A&M University. He has previously contributed to four books on nanomedicine and nanomaterials for biomedical applications. Prof Elsabahy completed M.Sc. and PhD degrees from the Faculty of Pharmacy, University of Montreal "Pharmaceutical Technology (Montreal, Canada). He has contributed to c. 90 top peer-reviewed publications, which mainly focused on furthering the use of nanotechnology in the targeted delivery of therapeutic and diagnostic agents, for which he has received several national and international prestigious awards.